Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Asset Utilization Ratio (2022 - 2025)

Taysha Gene Therapies (TSHA) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.03 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 39.47% to 0.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03 through Dec 2025, down 39.47% year-over-year, with the annual reading at 0.04 for FY2025, 22.44% down from the prior year.
  • Asset Utilization Ratio hit 0.03 in Q4 2025 for Taysha Gene Therapies, up from 0.02 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.09 in Q1 2024 to a low of 0.03 in Q4 2022.
  • Historically, Asset Utilization Ratio has averaged 0.05 across 4 years, with a median of 0.05 in 2024.
  • Biggest five-year swings in Asset Utilization Ratio: soared 526.79% in 2024 and later plummeted 62.73% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.03 in 2022, then surged by 418.08% to 0.08 in 2023, then plummeted by 41.65% to 0.05 in 2024, then crashed by 39.47% to 0.03 in 2025.
  • Business Quant data shows Asset Utilization Ratio for TSHA at 0.03 in Q4 2025, 0.02 in Q3 2025, and 0.03 in Q2 2025.